Dr. John W. Lindsey, MD

Dr. Lindsey practices at Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System.

Dr. Lindsey's NPI, 1003846619, was assigned on July 3, 2006. Dr. Lindsey graduated from Harvard Medical School in 1987. Dr. Lindsey's Texas license number on file is J5387.

Dr. Lindsey's primary practice is Memorial Hermann-Texas Medical Center, at 6411 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 704-3700.

Dr. Lindsey's primary practice is Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System. Dr. Lindsey is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Lindsey to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lindsey practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lindsey's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lindsey is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lindsey's licenses on file in 2 states: Texas and California.

Dmand AI lists multiple sclerosis among the conditions Dr. Lindsey treats.

CMS data shows 155 Medicare services from Dr. Lindsey across 3 procedure codes in 2024, for 67 Medicare patients. Medicare paid $9,719 for them. Every service was in an office.

CMS counts 67 Medicare patients who saw Dr. Lindsey in 2024. The largest group is 65 to 74, with 33 patients. 72% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lindsey's median patient age at 52, with 70% women.

In 2024, Dr. Lindsey wrote 1,760 Medicare Part D claims for 142 patients. 86% of them were for generic drugs. CMS names the drug for 1,506 of them, across 45 drugs with 11 or more claims each, at $2,229,454 in total drug cost. In 2023, CMS named 1,531 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Lindsey for performance year 2024, reported as part of a group. Dr. Lindsey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lindsey as offering telehealth.

Dmand AI links 38 papers to Dr. Lindsey, published from 2007 to 2024. 2015 was the busiest year, with 3. The most frequent topics are Multiple Sclerosis, Herpesvirus 4, Human and Encephalomyelitis, Autoimmune, Experimental. Dr. Lindsey has published most often in J Neuroimmunol. Dr. Lindsey's most frequent co-authors are Lawrence Steinman, MD, John Anil Lincoln, MD, PhD and Jon Marc Rhoads, MD.

Dmand AI links Dr. Lindsey to 11 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 338 general payments to Dr. Lindsey from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. EMD Serono, Inc. paid the most, $77,207. It also lists 11 research payments totaling $2,917 from 2017 to 2021.

Dmand AI lists 1 award for Dr. Lindsey, most recently CMS Stage 1 2012 in 2011.

Dr. Lindsey graduated from Harvard Medical School in 1987.

Dr. Lindsey is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.